Immunotherapy is a type of cancer treatment that helps your immune system fight cancer. The immune system helps your body fight infections and other diseases. It is made up of white blood cells and organs and tissues of the lymph system. When cancer appears some of the body’s cells begin to divide without stopping and spread into surrounding tissues, generating abnormal cell growth. These extra cells can divide without stopping and may form growths called tumours. One reason that cancer cells thrive is because they are able to hide from your immune system. Certain immunotherapies can mark cancer cells, so it is easier for the immune system to find and destroy them. Other immunotherapies boost your immune system to work better against cancer. Cancer can start almost anywhere in the human body, which is made up of trillions of cells. Normally, human cells grow and divide to form new cells as and when the body needs them. In the normal process when cells grow old or become damaged they die, and new cells take their place. When cancer develops, however, this orderly process breaks down. As cells become more and more abnormal, old or damaged cells survive when they should die, and new cells form when they are not needed.
Focus on cancer treatment
At Stem Cells 21/ImmuneCells21, our immunotherapy cancer treatment is a combination programme, which utilise scientifically proven therapies to destroy cancer and enhance immunity. Our cancer treatment programme’s major focus points are:
- Increasing cancer cell death with photodynamic therapies with laser stimulation
- Increasing the number of active immune cells in the body.
- Stimulating your own immune system to work harder or smarter to attack cancer cells.
- Supporting your immune system with essential components, such as immune system proteins and anti-cancer nutrients.
- CTC (Circulating Tumour Cells) Blood Test: This special test is to analyse the tumour markers that are present in the tumour and in the blood circulation. It is also a crucial test to determine what Biological/Natural substances are sensitive to the type of tumour, that can be used for as anticancer nutrients such as Cur-cumin, CoQ10, Artesunate, Hypericin, Alpha lipoic acid, Genistein, Quercetin, Resveratrol, GcMAF and many others as a combination therapy.
Natural killer cell therapy (NK cell therapy) is a type of immunotherapy cancer treatment used to kill cancerous or infected cells. This form of immunotherapy is a treatment based on the kind of T-cell group commonly known as lymphocytes which play a key role in the immune system’s response capabilities. The autologous killer cell therapy process involves the activation of killer cells and the infusion of these cells into the patients body.
Natural Killer (NK) cells are innate immune cells which lyse infected and malignantly transformed cells (cancer cells) by cytotoxic activity. Cytotoxic NK cells contain high numbers of secretory granules which store and release death inducing proteins such as perforin and granzymes. Perforin facilitates the delivery of serine proteases known as granzymes into the target cell by forming a pore either on the endosome or plasma membrane of the target cell. The granzymes released activate 3 distinct pathways of apoptosis in the target cell. In humans, granzyme B (GrzB) and granzyme A (GrzA) are the most potent activators of apoptosis (cancer/infected cell death). NK cells also initiate target cell apoptosis (cancer/infected cell death) through tumour necrosis factor (TNF) ligands expressed on NK cells to induce apoptosis.
NK Cells Therapy for Cancer at SC21/ImmuneCells21:
Our Natural Killer Cell Therapy allows for an increase of activated immune cells which act as the bodies army to begin their assault on unwanted cells such as cancer cells.
At SC21/ImmuneCells21, our Immunotherapy is a combination of PDT
(Photodynamic Therapy) + NK Cells Therapy which takes around 5-6 weeks treatment duration.
We produce the NK21 – Natural Killer Cells for Cancer. The protocol we have developed produces 2 infusions of cytotoxic killer cells per blood collection (100ml).
The NK cells are cultured and released for therapeutic use on day 18 and day 21.
In a full cancer treatment programme, we will perform 3 blood collections (weekly) and NK cultures, giving a total of 6 cytotoxic killer cell infusions on specific days.
In between NK cells infusion, IV infusion of biological/natural substances plus all supportive therapies such as IV medical laser, IV oxygen, External IR laser therapy, Specific RNA peptide injection and physiotherapy are given daily depending on the clinical conditions of the patient
Photodynamic therapy (PDT cancer treatment) is one of the most promising medical approaches for the treatment of many different types of cancer. The principle is the stimulation of a light-sensitive substance based on natural chlorophyll (photo sensitiser), which is given into the bloodstream intravenously and (or) injected locally into the tumour. The sensitiser binds to any type of tumour cell in the organ/s with very high specificity. After stimulation with (medical laser) light, these are destroyed through the formation of active oxygen radicals.
As a rule, photo sensitisers are made up of porphyrin molecules or similar structures and are usually derivatives of haem or chlorophyll.
The most modern and selective photo sensitiser at present is our Liposomal Indocyanine green (ICG) stimulated with Weber Medical IR laser system. We choose Weber Medical for their superior quality of equipment which is manufactured in Germany. When using any medical laser, proper calibrations and control systems are required for safety and efficiency.
A particular advantage of photodynamic therapy for cancer, as opposed to traditional chemotherapy, is that the immune system is not put under stress, but instead is strengthened by the intravenous laser therapy in the after-treatment, whereby there is an additional secondary immunisation effect of the photodynamic therapy (PDT-immunisation).
At StemCells21/ImmuneCells 21 we offer:
1. Immune Boosting
2. Cancer Treatment
3. Immune Cell Banking